Therefore, the low expression of CD247 may promote inflammation in SLE by upregulating the regulation of non-canonical NF-kB signaling transduction and may further affect the immune suppression and tumor progression in DLBCL through changes in the immune microenvironment.. This evidence concerns the gene CD247 and neoplasm.